Logo image of ALMUN.PA

MUNIC (ALMUN.PA) Stock Fundamental Analysis

EPA:ALMUN - Euronext Paris - Matif - FR0013462231 - Common Stock - Currency: EUR

0.696  -0.01 (-0.85%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALMUN. ALMUN was compared to 25 industry peers in the Communications Equipment industry. ALMUN may be in some trouble as it scores bad on both profitability and health. ALMUN is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALMUN has reported negative net income.
ALMUN had a positive operating cash flow in the past year.
ALMUN had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALMUN reported negative operating cash flow in multiple years.
ALMUN.PA Yearly Net Income VS EBIT VS OCF VS FCFALMUN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 2M -2M -4M -6M

1.2 Ratios

ALMUN has a Return On Assets (-6.82%) which is in line with its industry peers.
ALMUN has a Return On Equity (-13.86%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -6.82%
ROE -13.86%
ROIC N/A
ROA(3y)-2.63%
ROA(5y)-8.15%
ROE(3y)-5.44%
ROE(5y)-448.31%
ROIC(3y)N/A
ROIC(5y)N/A
ALMUN.PA Yearly ROA, ROE, ROICALMUN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K -1.5K -2K

1.3 Margins

ALMUN has a better Gross Margin (61.40%) than 72.00% of its industry peers.
In the last couple of years the Gross Margin of ALMUN has grown nicely.
ALMUN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.4%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.95%
GM growth 5Y9.57%
ALMUN.PA Yearly Profit, Operating, Gross MarginsALMUN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

More info and screens

3

2. Health

2.1 Basic Checks

ALMUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALMUN has about the same amout of shares outstanding than it did 1 year ago.
ALMUN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ALMUN has been reduced compared to a year ago.
ALMUN.PA Yearly Shares OutstandingALMUN.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
ALMUN.PA Yearly Total Debt VS Total AssetsALMUN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 0.11, we must say that ALMUN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ALMUN (0.11) is worse than 84.00% of its industry peers.
The Debt to FCF ratio of ALMUN is 1.86, which is an excellent value as it means it would take ALMUN, only 1.86 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALMUN (1.86) is better than 80.00% of its industry peers.
ALMUN has a Debt/Equity ratio of 0.41. This is a healthy value indicating a solid balance between debt and equity.
ALMUN has a Debt to Equity ratio (0.41) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.86
Altman-Z 0.11
ROIC/WACCN/A
WACC5.75%
ALMUN.PA Yearly LT Debt VS Equity VS FCFALMUN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 1.25 indicates that ALMUN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.25, ALMUN is doing worse than 80.00% of the companies in the same industry.
A Quick Ratio of 0.88 indicates that ALMUN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.88, ALMUN is doing worse than 68.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.88
ALMUN.PA Yearly Current Assets VS Current LiabilitesALMUN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

More info and screens

4

3. Growth

3.1 Past

ALMUN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.31%, which is quite impressive.
ALMUN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.48%.
Measured over the past years, ALMUN shows a decrease in Revenue. The Revenue has been decreasing by -0.61% on average per year.
EPS 1Y (TTM)20.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.74%
Revenue 1Y (TTM)-31.48%
Revenue growth 3Y25.13%
Revenue growth 5Y-0.61%
Sales Q2Q%-29.55%

3.2 Future

ALMUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 58.11% yearly.
Based on estimates for the next years, ALMUN will show a very strong growth in Revenue. The Revenue will grow by 21.72% on average per year.
EPS Next Y150%
EPS Next 2Y58.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year50%
Revenue Next 2Y21.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALMUN.PA Yearly Revenue VS EstimatesALMUN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
ALMUN.PA Yearly EPS VS EstimatesALMUN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2023 2024 2025 0 -0.2 -0.4 -0.6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMUN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 67.57, which means the current valuation is very expensive for ALMUN.
ALMUN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. ALMUN is more expensive than 64.00% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.44. ALMUN is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 67.57
ALMUN.PA Price Earnings VS Forward Price EarningsALMUN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

68.00% of the companies in the same industry are more expensive than ALMUN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALMUN is valued cheaper than 96.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.23
EV/EBITDA 8.86
ALMUN.PA Per share dataALMUN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALMUN's earnings are expected to grow with 58.11% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y58.11%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMUN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MUNIC

EPA:ALMUN (7/18/2025, 7:00:00 PM)

0.696

-0.01 (-0.85%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)01-28 2025-01-28
Earnings (Next)07-23 2025-07-23
Inst Owners1.69%
Inst Owner ChangeN/A
Ins Owners26.88%
Ins Owner ChangeN/A
Market Cap6.24M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 67.57
P/S 0.48
P/FCF 2.23
P/OCF 1.18
P/B 0.58
P/tB N/A
EV/EBITDA 8.86
EPS(TTM)-0.17
EYN/A
EPS(NY)0.01
Fwd EY1.48%
FCF(TTM)0.31
FCFY44.76%
OCF(TTM)0.59
OCFY84.9%
SpS1.44
BVpS1.21
TBVpS-0.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.82%
ROE -13.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.4%
FCFM 21.68%
ROA(3y)-2.63%
ROA(5y)-8.15%
ROE(3y)-5.44%
ROE(5y)-448.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.95%
GM growth 5Y9.57%
F-Score5
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 1.86
Debt/EBITDA 5.66
Cap/Depr 97.43%
Cap/Sales 19.44%
Interest Coverage N/A
Cash Conversion 678.26%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.88
Altman-Z 0.11
F-Score5
WACC5.75%
ROIC/WACCN/A
Cap/Depr(3y)373.79%
Cap/Depr(5y)531.76%
Cap/Sales(3y)17.82%
Cap/Sales(5y)20.36%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.31%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%14.74%
EPS Next Y150%
EPS Next 2Y58.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.48%
Revenue growth 3Y25.13%
Revenue growth 5Y-0.61%
Sales Q2Q%-29.55%
Revenue Next Year50%
Revenue Next 2Y21.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y36.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2300%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y149.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y367.24%
OCF growth 3YN/A
OCF growth 5Y-13%